Reactor production of Thorium-229

Susan Hogle, Rose Ann Boll, Karen Murphy, David Denton, Allison Owens, Tamara J. Haverlock, Marc Garland, Saed Mirzadeh

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Abstract

Limited availability of 229Th for clinical applications of 213Bi necessitates investigation of alternative production routes. In reactor production, 229Th is produced from neutron transmutation of 226Ra, 228Ra, 227Ac and 228Th. Irradiations of 226Ra, 228Ra, and 227Ac targets at the Oak Ridge National Laboratory High Flux Isotope Reactor result in yields of 229Th at 26 days of 74.0±7.4 MBq/g, 260±10 MBq/g, and 1200±50 MBq/g, respectively. Intermediate radionuclide yields and cross sections are also studied.

Original languageEnglish
Pages (from-to)19-27
Number of pages9
JournalApplied Radiation and Isotopes
Volume114
DOIs
StatePublished - Aug 1 2016

Funding

This research is supported by the Isotope Program, Office of Nuclear Physics of the U.S. Department of Energy. ORNL is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725 .

Keywords

  • Actinium-225
  • Actinium-227
  • High flux isotope reactor
  • Isochain
  • Neutron reactions
  • Radium-226
  • Radium-228
  • Thorium-228
  • Thorium-229

Fingerprint

Dive into the research topics of 'Reactor production of Thorium-229'. Together they form a unique fingerprint.

Cite this